Baseline Dysgeusia in Chemotherapy-Naïve Non-Small Cell Lung Cancer Patients: Association with Nutrition and Quality of Life

References

• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359–86, 2015. doi: 10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• INEGI. Estadísticas de Mortalidad. Cubos dinámicos INEGI: México, 2012.
   Google Scholar
• Ginsberg RVR (ed.). Cancer of the Lung, Section 2: Nonsmall Cell Lung Cancer. In: Cancer: Principles & Practice. Lippincott Williams & Wilkins: Rosenberg SA, 1997, pp. 858.
   Google Scholar
• Sanchez-Lara K, Turcott JG, Juarez-Hernandez E, Nunez-Valencia C, Villanueva G, et al. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial. Clin Nutr 33, 1017–1023, 2014. doi: 10.1016/j.clnu.2014.03.006
   PubMed Web of Science ®Google Scholar
• Arrieta O, Guzman-de Alba E, Alba-Lopez LF, Acosta-Espinoza A, Alatorre-Alexander J, et al. [National consensus of diagnosis and treatment of non-small cell lung cancer]. Rev Investig Clin 65, S5–S84, 2013.
   PubMedGoogle Scholar
• Arrieta O, Michel Ortega RM, Villanueva-Rodriguez G, Serna-Thome MG, Flores-Estrada D, et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 10, 50, 2010. doi: 10.1186/1471-2407-10-50
   PubMed Web of Science ®Google Scholar
• Belqaid K, Orrevall Y, McGreevy J, Mansson-Brahme E, Wismer W, et al. Self-reported taste and smell alterations in patients under investigation for lung cancer. Acta Oncol 53, 1405–1412, 2014. doi: 10.3109/0284186X.2014.895035
   PubMed Web of Science ®Google Scholar
• Sanchez-Lara K, Sosa-Sanchez R, Green-Renner D, Rodriguez C, Laviano A, et al. Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy. Nutr J 9, 15, 2010. doi: 10.1186/1475-2891-9-15
   PubMed Web of Science ®Google Scholar
• Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, Ohrn KE, et al. A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18, 1081–1087, 2010. doi: 10.1007/s00520-010-0902-1
   PubMed Web of Science ®Google Scholar
• Imai H, Soeda H, Komine K, Otsuka K, and Shibata H: Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer. BMC Palliat Care 12, 38, 2013. doi: 10.1186/1472-684X-12-38
   PubMed Web of Science ®Google Scholar
• Kano T, and Kanda K: Development and validation of a chemotherapy-induced taste alteration scale. Oncol Nurs Forum 40, E79–85, 2013. doi: 10.1188/13.ONF.E79-E85
   PubMedGoogle Scholar
• McGreevy J, Orrevall Y, Belqaid K, Wismer W, Tishelman C, et al. Characteristics of taste and smell alterations reported by patients after starting treatment for lung cancer. Support Care Cancer 22, 2635–2644, 2014. doi: 10.1007/s00520-014-2215-2
   PubMed Web of Science ®Google Scholar
• Coa KI, Epstein JB, Ettinger D, Jatoi A, McManus K, et al. The impact of cancer treatment on the diets and food preferences of patients receiving outpatient treatment. Nutr Cancer 67, 339–353, 2015. doi: 10.1080/01635581.2015.990577
   PubMed Web of Science ®Google Scholar
• de Cos Escuin JS, Delgado IU, Rodriguez JC, Lopez MJ, Vicente CD, et al. [Stage IIIA and IIIB non-small cell lung cancer: results of chemotherapy combined with radiation therapy and analysis of prognostic factors]. Arch Bronconeumol 43, 358–365, 2007.
   PubMed Web of Science ®Google Scholar
• Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29, 154–159, 2010. doi: 10.1016/j.clnu.2009.12.004
   PubMed Web of Science ®Google Scholar
• Turcott JG, Onate-Ocana LF, Soca-Chafre G, Ramirez-Tirado LA, Flores-Estrada D, et al. FAACT-anorexia cachexia scale: cutoff value for anorexia diagnosis in advanced non-small cell lung cancer patients. Nutr Cancer 71, 409–417, 2018. doi: 10.1080/01635581.2018.1506488
   PubMed Web of Science ®Google Scholar
• Hernandez-Avila M, Romieu I, Parra S, Hernandez-Avila J, Madrigal H, et al. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex 40, 133–140, 1998.
   PubMed Web of Science ®Google Scholar
• Arrieta O, Nunez-Valencia C, Reynoso-Erazo L, Alvarado S, Flores-Estrada D, et al. Health-related quality of life in patients with lung cancer: validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire. Lung Cancer 77, 205–211, 2012. doi: 10.1016/j.lungcan.2012.02.005
   PubMed Web of Science ®Google Scholar
• Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, and Sullivan M: The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 30A, 635–642, 1994. doi: 10.1016/0959-8049(94)90535-5
   PubMed Web of Science ®Google Scholar
• Syed Q, Hendler KT, and Koncilja K: The impact of aging and medical status on dysgeusia. Am J Med 129, 753.e1–753.e6, 2016. doi: 10.1016/j.amjmed.2016.02.003
   PubMed Web of Science ®Google Scholar
• Ponticelli E, Clari M, Frigerio S, De Clemente A, Bergese I, et al. Dysgeusia and health-related quality of life of cancer patients receiving chemotherapy: A cross-sectional study. Eur J Cancer Care (Engl) 26, 2017. doi: 10.1111/ecc.12633
   PubMed Web of Science ®Google Scholar
• Vigarios E, Epstein JB, and Sibaud V: Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors. Support Care Cancer 25, 1713–1739, 2017. doi: 10.1007/s00520-017-3629-4
   PubMed Web of Science ®Google Scholar
• Lau SKM, Gannavarapu BS, Carter K, Gao A, Ahn C, et al. Impact of socioeconomic status on pretreatment weight loss and survival in non-small-cell lung cancer. JOP 14, e211–e220, 2018. doi: 10.1200/JOP.2017.025239
   PubMed Web of Science ®Google Scholar
• Turcott JG, Del Rocio Guillen Nunez M, Flores-Estrada D, Onate OL, Zatarain-Barron ZL, et al. The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial. Support Care Cancer 26, 3029–3038, 2018. doi: 10.1007/s00520-018-4154-9
   PubMed Web of Science ®Google Scholar
• Kumbargere Nagraj S, George RP, Shetty N, Levenson D, Ferraiolo DM, et al. Interventions for managing taste disturbances. Cochrane Database Syst Rev 12, CD010470, 2017. doi: 10.1002/14651858.CD010470.pub3
   PubMed Web of Science ®Google Scholar
• Brisbois TD, de Kock IH, Watanabe SM, Mirhosseini M, Lamoureux DC, et al. Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol 22, 2086–2093, 2011. doi: 10.1093/annonc/mdq727
   PubMed Web of Science ®Google Scholar
• Sanchez-Lara K, Arrieta O, Pasaye E, Laviano A, Mercadillo RE, et al. Brain activity correlated with food preferences: a functional study comparing advanced non-small cell lung cancer patients with and without anorexia. Nutrition 29, 1013–1019, 2013. doi: 10.1016/j.nut.2013.01.020
   PubMed Web of Science ®Google Scholar
• Arrieta O, De la Torre-Vallejo M, Lopez-Macias D, Orta D, Turcott J, et al. Nutritional status, body surface, and low lean body mass/body mass index are related to dose reduction and severe gastrointestinal toxicity induced by afatinib in patients with non-small cell lung cancer. Oncologist 20, 967–974, 2015. doi: 10.1634/theoncologist.2015-0058
   PubMed Web of Science ®Google Scholar
• Sanchez-Lara K, Turcott JG, Juarez E, Guevara P, Nunez-Valencia C, et al. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study. Nutr Cancer 64, 526–534, 2012. doi: 10.1080/01635581.2012.668744
   PubMed Web of Science ®Google Scholar